Suppr
超能文献

Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

作者信息

Lichtenstein Steven J, Granet David B

机构信息

Associate Clinical Professor of Pediatrics and Surgery, University of Illinois College of Medicine at Peoria and Chicago, Peoria, IL, USA.

出版信息

Clin Ophthalmol. 2008 Mar;2(1):241-2. doi: 10.2147/opth.s2819.

DOI:10.2147/opth.s2819

PMID:19668414

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2698698/

Abstract

摘要

相似文献

Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

Clin Ophthalmol. 2008 Mar;2(1):241-2. doi: 10.2147/opth.s2819.

Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis.

Patient Prefer Adherence. 2010 May 13;4:69-76. doi: 10.2147/ppa.s4203.

A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis.

Clin Ophthalmol. 2007 Jun;1(2):177-82.

Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

Clin Ophthalmol. 2008 Mar;2(1):242-4.

Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.

Am J Ophthalmol. 2008 Jun;145(6):959-65. doi: 10.1016/j.ajo.2008.01.019. Epub 2008 Mar 28.

Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.

Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9. doi: 10.1167/iovs.06-1413.

Ocular pharmacokinetics of AzaSite Xtra-2% azithromycin formulated in a DuraSite delivery system.

Curr Eye Res. 2009 Jun;34(6):485-91. doi: 10.1080/02713680902919532.

An anterior chamber toxicity study evaluating Besivance, AzaSite, and Ciprofloxacin.

Am J Ophthalmol. 2010 Oct;150(4):498-504.e1. doi: 10.1016/j.ajo.2010.05.006. Epub 2010 Aug 3.

The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.

Adv Ther. 2008 Mar;25(3):208-17. doi: 10.1007/s12325-008-0034-x.

[Evaluation of effectiveness and tolerance of treatment with azithromycin 1.5% eye drops in bacterial conjunctivitis].

Klin Oczna. 2009;111(1-3):46-9.

引用本文的文献

Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections.

Ophthalmol Eye Dis. 2012 Feb 23;4:1-14. doi: 10.4137/OED.S7791. Print 2012.

The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Clin Drug Investig. 2011;31(8):543-557. doi: 10.2165/11589020-000000000-00000.

Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis.

Patient Prefer Adherence. 2010 May 13;4:69-76. doi: 10.2147/ppa.s4203.

本文引用的文献

An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.

Clin Ophthalmol. 2007 Dec;1(4):519-25.

Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.

Clin Ophthalmol. 2007 Mar;1(1):3-10.

Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis.

Curr Med Res Opin. 2007 Sep;23(9):2241-9. doi: 10.1185/030079907X226276.

Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?

Clin Infect Dis. 2004 Nov 15;39(10):1554-6; author reply 1556-7. doi: 10.1086/425508.

Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.

Surv Ophthalmol. 2004 Mar;49 Suppl 2:S79-83. doi: 10.1016/j.survophthal.2004.01.004.

Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure.

J Antimicrob Chemother. 2001 Sep;48(3):375-81. doi: 10.1093/jac/48.3.375.

Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.

Ophthalmology. 1999 Jul;106(7):1313-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译